← All organizations
Highest phase reached
Phase 4
First clinical trial
Jul 1, 2006Last known activity
Oct 27, 2020
Timeline
1960s
- Jun 1, 1961
Hospital Santa Marcelina, Sao Paulo, Brasil— Founded
Drugs by trial phase (15 distinct, 15 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (8 own, 0 via acquisition)
Phase 2 (6 own, 0 via acquisition)
Indications
Studied for
- Cerebral Infarction
- Coronavirus Infections
- Dyslipidemias
- Hemorrhoids
- Hypertension
- Inflammation
- Ischemia
- Leukemia
- Leukemia, Lymphoid
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Low Back Pain
- Lymphoma
- Neoplasms
- Osteosarcoma
- Philadelphia Chromosome
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
- Rhabdomyosarcoma
- Sarcoma
- Stroke
- Venous Insufficiency
Recent trials (22)
- NCT04610567CollaboratorPhase 1/Phase 2Oct 27, 2020
- NCT04352465CollaboratorPhase 1/Phase 2May 1, 2020
- NCT01587508Overall official - principal investigatorPhase 3May 1, 2013
- NCT01643967Overall official - principal investigatorPhase 3Jun 30, 2012
- NCT01643967OfficialPhase 3Jun 30, 2012
- NCT01191450Overall official - principal investigatorPhase 3Aug 1, 2011
- NCT01321619Overall official - principal investigatorPhase 3Jul 1, 2011
- NCT01216826Lead sponsorPhase 2Mar 1, 2011
- NCT01216839Lead sponsorPhase 2Mar 1, 2011
- NCT01558453Lead sponsorPhase 2Mar 1, 2011
- NCT01216839Sponsor investigatorPhase 2Mar 1, 2011
- NCT01216826Sponsor investigatorPhase 2Mar 1, 2011
- NCT01216826Overall official - principal investigatorPhase 2Mar 1, 2011
- NCT01558453Sponsor investigatorPhase 2Mar 1, 2011
- NCT01558453Study chairPhase 2Mar 1, 2011
Details
- Founded
- Sao Paulo, BR Jun 1, 1961
- Last known activity
- Oct 27, 2020